![Dana Moss](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dana Moss
Direktor/Vorstandsmitglied bei NAVIDEA BIOPHARMACEUTICALS, INC.
Vermögen: - $ am 31.05.2024
Profil
Dana J.
Moss is an Independent Director at Navidea Biopharmaceuticals, Inc. since 2023.
Previously, Ms. Moss served as Secretary & Chief Legal Officer at Sequencing Health.
Ms. Moss completed their undergraduate degree at the United States Air Force Academy and their graduate degree at The University of Texas at Austin.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
16.11.2023 | 866 667 ( 0,87% ) | - $ | 31.05.2024 |
Aktive Positionen von Dana Moss
Unternehmen | Position | Beginn |
---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.07.2023 |
Ehemalige bekannte Positionen von Dana Moss
Unternehmen | Position | Ende |
---|---|---|
Sequencing Health
![]() Sequencing Health Miscellaneous Commercial ServicesCommercial Services Sequencing Health develops DNA sequencing technology. The private company is based in Atlanta, GA and has subsidiaries in the United States. The CEO of the company is Jason W. Myers. | General Counsel | - |
Ausbildung von Dana Moss
The University of Texas at Austin | Graduate Degree |
United States Air Force Academy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Sequencing Health
![]() Sequencing Health Miscellaneous Commercial ServicesCommercial Services Sequencing Health develops DNA sequencing technology. The private company is based in Atlanta, GA and has subsidiaries in the United States. The CEO of the company is Jason W. Myers. | Commercial Services |